Diagnosis: Hemoconcentration with Possible Tumor Lysis Syndrome
The most likely diagnosis is hemoconcentration (evidenced by elevated hemoglobin 174 g/L) with possible early tumor lysis syndrome or other cause of metabolic acidosis, given the normal anion gap of 14 mmol/L, low phosphate 0.79 mmol/L, and elevated calcium 2.57 mmol/L.
Laboratory Analysis
Hemoglobin Elevation
- Hemoglobin 174 g/L is significantly elevated above the normal range of 120-150 g/L for non-pregnant adults 1
- This degree of elevation suggests hemoconcentration from volume depletion, dehydration, or a primary polycythemic process
- The normal RDW CV of 11.4% indicates uniform red cell size, making hemolysis or nutritional deficiencies less likely
Urea and Renal Function
- Urea 7.5 mmol/L is at the upper limit of normal (normal range 2.5-7.5 mmol/L) 1
- In pregnancy, normal urea ranges from 2.4-4.2 mmol/L depending on trimester 1, but this patient's context is unclear
- This borderline elevation combined with hemoconcentration suggests prerenal azotemia from volume depletion
Anion Gap Assessment
- Anion gap of 14 mmol/L is within normal limits (typically 8-16 mmol/L with potassium included) 1
- A normal anion gap with these other abnormalities argues against advanced renal failure, which typically presents with anion gap >20 mmol/L when GFR falls below 20 mL/min 2
- The absence of elevated anion gap makes diabetic ketoacidosis, lactic acidosis, and advanced uremia less likely 3
Phosphate and Calcium
- Phosphate 0.79 mmol/L is low (normal range approximately 0.8-1.5 mmol/L)
- Calcium 2.57 mmol/L is elevated (normal range 2.1-2.5 mmol/L) 1
- This combination of hypophosphatemia with hypercalcemia is unusual and clinically significant 4
- The elevated calcium-to-phosphate ratio suggests possible malignancy-related hypercalcemia, primary hyperparathyroidism, or other causes of PTH-mediated or PTH-independent hypercalcemia 5
Differential Diagnosis Priority
Most Likely: Hemoconcentration with Hypercalcemia
- The constellation of elevated hemoglobin, borderline-high urea, normal anion gap, and hypercalcemia with hypophosphatemia points toward volume depletion with an underlying calcium disorder
- Hypercalcemia of malignancy must be ruled out, particularly lung cancer or multiple myeloma, which can present with both hypercalcemia and potential volume depletion 5
Less Likely: Early Chronic Kidney Disease
- While urea is at the upper limit, the normal anion gap argues against significant renal impairment 2, 3
- In CKD with GFR <20 mL/min, anion gap typically exceeds 20 mmol/L and phosphate is elevated, not decreased 2
Ruled Out: Tumor Lysis Syndrome
- Classic TLS presents with hyperphosphatemia (not hypophosphatemia), hypocalcemia (not hypercalcemia), and elevated anion gap 6, 4
- This patient's laboratory pattern is the opposite of TLS
Recommended Management Algorithm
Immediate Actions
Obtain additional critical laboratories:
Assess volume status clinically:
- Orthostatic vital signs
- Mucous membrane moisture
- Skin turgor
- Urine output and concentration
If severe hypercalcemia confirmed (>3.0 mmol/L or symptomatic):
Diagnostic Workup
- If PTH is suppressed: Measure PTHrP to evaluate for malignancy-related hypercalcemia 5
- If PTH is elevated or inappropriately normal: Consider primary hyperparathyroidism
- Chest imaging to evaluate for lung malignancy 5
- Serum and urine protein electrophoresis if multiple myeloma suspected 5
Critical Pitfalls to Avoid
- Do not assume normal renal function based on urea alone—creatinine is essential, as urea can be falsely low with malnutrition or falsely elevated with volume depletion 1
- Do not aggressively treat hypophosphatemia without addressing hypercalcemia first, as phosphate supplementation in the setting of hypercalcemia risks metastatic calcification when calcium-phosphate product exceeds 55 mg²/dL² 4
- Do not overlook malignancy—the combination of hypercalcemia with volume depletion carries a poor prognosis if malignancy-related, with median survival of approximately 1 month in lung cancer patients 5